Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD
Open accessAbstract
BACKGROUND: Over the last decade the use of psychotropic medications to treat common mental health problems has increased in Australia. This paper explores: 1) public attitudes towards the acceptability of using prescription drugs to treat depression and attention deficit hyperactivity disorder (ADHD), and 2) beliefs about over-diagnosis of depression and ADHD. METHOD: 1293 members of the general public were surveyed about their attitudes towards drug treatment for depression and ADHD through the Queensland Social Survey (QSS), an omnibus state-wide survey of households in the state of Queensland. The survey was administered through a CATI (computer-assisted telephone interviewing) system. Logistic regression analyses were used to predict belief that drug treatment is acceptable, and that depression and ADHD are over-diagnosed. RESULTS: Most participants (60.9%) said that it was acceptable to use prescription drugs to treat depression. In contrast, attitudes towards the use of prescription drugs to treat ADHD were much less positive with around the same proportion saying it was acceptable (42.1%) as unacceptable (38.2%). More than half of the sample agreed that too many people are diagnosed with depression when they don't really have it (57.7%), and 78.3% of participants agreed that too many children are diagnosed with ADHD when they don't really have it. Participants who said depression or ADHD were over-diagnosed were less likely to say that it is acceptable to treat these conditions with prescription drugs. CONCLUSIONS: Despite increases in prescribing rates there is still considerable scope for increasing the public's acceptance of treating common mental illnesses with psychotropic drugs. Furthermore, the public's views on over-diagnosis of depression and ADHD appear to reflect ongoing controversy about the proper identification of these conditions, and these views negatively impact attitudes towards drug treatment. This may be a barrier to effective treatment of these conditions given that drug treatment is often recommended as a first line response.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cultural context is relevant, and biological and sociological explanatory models appear to contribute differentially to stigma based on cultural values.
“However, cultural context is also relevant, and biological and sociological explanatory models appear to contribute differentially to stigma based on cultural values. 360”
From Time for united action on depression: a Lancet–World Psychiatric Association Commission (2022) · cites this paper as [360]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Jorm, A. F., Korten, A. E., Jacomb, P. A., Christensen, H., Rodgers, B., & Pollitt, P. (1997) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb140071.x · Cited by 2,585 · see citing works
Mental health literacy: Public knowledge and beliefs about mental disorders
Jorm, A. F. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.5.396 · Cited by 2,114 · see citing works
Pescosolido, B. A., Martin, J. K., Long, J. S., Medina, T. R., Phelan, J. C., & Link, B. G. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09121743 · Cited by 1,262 · see citing works
Bruchmüller, K., Margraf, J., & Schneider, S. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0026582 · Cited by 354 · see citing works
Reavley, N. J., & Jorm, A. F. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.621060 · Cited by 271 · see citing works
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217 · see citing works
Affective and anxiety disorders: prevalence, treatment and antidepressant medication use.
Hollingworth, S., Burgess, P. M., & Whiteford, H. (2010) · PubMed · doi:10.3109/00048670903555138 · Cited by 207 · see citing works
Dahlberg, K., Wærn, M., & Runeson, B. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-8 · Cited by 148 · see citing works
McLeod, J. D., Fettes, D. L., Jensen, P. S., Pescosolido, B. A., & Martin, J. K. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.5.626 · Cited by 130 · see citing works
Attention-deficit/hyperactivity disorder: are we helping or harming?
Thomas, R., Mitchell, G. K., & Batstra, L. (2013) · BMJ · doi:10.1136/bmj.f6172 · Cited by 109 · see citing works
Is depression overdiagnosed? Yes
Parker, G. B. (2007) · BMJ · doi:10.1136/bmj.39268.475799.ad · Cited by 105 · see citing works
DSM-5 Further Inflates Attention Deficit Hyperactivity Disorder
Batstra, L., & FRANCES, A. J. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318257c4b6 · Cited by 79 · see citing works
Public Attitudes toward the Use of Psychiatric Medications for Children
McLeod, J. D., Pescosolido, B. A., Takeuchi, D. T., & White, T. F. (2004) · Journal of Health and Social Behavior · doi:10.1177/002214650404500104 · Cited by 71 · see citing works
Jorm, A. F., Christensen, H. M., & Griffiths, K. M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.06.002 · Cited by 57 · see citing works
Partridge, B., Lucke, J. C., & Hall, W. (2012) · AJOB Primary Research · doi:10.1080/21507716.2012.720639 · Cited by 40 · see citing works
Self-citationAustralian National Trends in Stimulant Dispensing: 2002–2009
Hollingworth, S., Nissen, L. M., Stathis, S. S., Siskind, D. J., Varghese, J. M. N., & Scott, J. G. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.543413 · Cited by 39 · see citing works
An Evaluation ofbeyondblue, Australia's National Depression Initiative
Pirkis, J., Hickie, I. B., Young, L., Burns, J. M., Highet, N. J., & Davenport, T. A. (2005) · International Journal of Mental Health Promotion · doi:10.1080/14623730.2005.9721865 · Cited by 38 · see citing works
Stroh, J., Frankenberger, W. R., Cornell-Swanson, L. V., Wood, C., & Pahl, S. (2007) · Journal of Child and Family Studies · doi:10.1007/s10826-007-9149-y · Cited by 34 · see citing works
Is depression overdiagnosed? No
Hickie, I. B. (2007) · BMJ · doi:10.1136/bmj.39268.497350.ad · Cited by 31 · see citing works
Public attitudes towards the acceptability of using drugs to treat depression and ADHD
Partridge, B., Lucke, J. C., & Hall, W. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412450755 · Cited by 24 · see citing works
Self-citationCommunity Knowledge and Beliefs About ADHD
Gilmore, L. (2010) · The Australian Educational and Developmental Psychologist · doi:10.1375/aedp.27.1.20 · Cited by 20 · see citing works
FRANCES, A. J. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412453775 · Cited by 18 · see citing works
Belief in the harmfulness of antidepressants: Associated factors and change over 16years
Reavley, N. J., & Jorm, A. F. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.012 · Cited by 14 · see citing works
Lee, S. (2007) · BMJ · doi:10.1136/bmj.39317.492130.be · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015) · Pediatrics · doi:10.1542/peds.2014-3482 · Cited by 1,976 · see citing works
Time for united action on depression: a Lancet–World Psychiatric Association Commission
Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104 · see citing works
Lissak, G. (2018) · Environmental Research · doi:10.1016/j.envres.2018.01.015 · Cited by 1,024 · see citing works
Angermeyer, M. C., van der Auwera, S., Carta, M. G., & Schomerus, G. (2017) · World Psychiatry · doi:10.1002/wps.20383 · Cited by 253 · see citing works
Parent-perceived barriers to accessing services for their child’s mental health problems
Hansen, A. S., Telléus, G. K., Jensen, C. M., & Lauritsen, M. B. (2021) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-021-00357-7 · Cited by 116 · see citing works
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives
Persico, A. M., Arango, C., Buitelaar, J. K., Correll, C. U., Glennon, J. C., Hoekstra, P. J., Moreno, C., Vitiello, B., Vorstman, J. A. S., & Zuddas, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.009 · Cited by 71 · see citing works
Wang, L., Lee, S.-Y., Yuan, S.-S., Yang, C., Yang, K., Huang, T., Chou, W.-J., Chou, M., Lee, M., Lee, T., et al. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000500 · Cited by 68 · see citing works
Rozbroj, T., Haas, R., O’Connor, D. A., Carter, S. M., McCaffery, K. J., Thomas, R., Donovan, J., & Buchbinder, R. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114255 · Cited by 50 · see citing works
Price, A., Newlove‐Delgado, T., Eke, H., Paul, M., Young, S., Ford, T. J., & Janssens, A. I. W. A. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2284-3 · Cited by 44 · see citing works
Defining and Evaluating Overdiagnosis in Mental Health: A Meta-Research Review
Thombs, B. D., Turner, K. A., & Shrier, I. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000501647 · Cited by 40 · see citing works
Recent Attitudes toward ADHD in the Broader Community: A Systematic Review
Bisset, M., Winter, L., Middeldorp, C. M., Coghill, D., Zendarski, N. J., Bellgrove, M. A., & Sciberras, E. (2021) · Journal of Attention Disorders · doi:10.1177/10870547211003671 · Cited by 39 · see citing works
Razoki, B. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s178839 · Cited by 35 · see citing works
Antidepressant use in Australia and Sweden—A cross‐country comparison
Eek, E., van Driel, M., Falk, M., Hollingworth, S., & Merlo, G. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5158 · Cited by 31 · see citing works
Managing the Risks of ADHD Treatments
Schneider, B. N., & Enenbach, M. J. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0479-3 · Cited by 30 · see citing works
Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Suseelan, S., & Pinna, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.09.001 · Cited by 26 · see citing works
Ghosh, M., Fisher, C. M., Preen, D. B., & Holman, C. D. J. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1399-1 · Cited by 25 · see citing works
Caro‐Cañizares, I., Serrano-Drozdowskyj, E., Pfang, B., Baca‐García, E., & Carballo, J. J. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717691829 · Cited by 18 · see citing works
Speerforck, S., Hertel, J., Stolzenburg, S., Grabe, H. J., Carta, M. G., Angermeyer, M. C., & Schomerus, G. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719855691 · Cited by 18 · see citing works
Ghosh, M., Holman, C. D. J., & Preen, D. B. (2017) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-017-0152-9 · Cited by 13 · see citing works
Morgan, P. L., Woods, A. D., & Wang, Y. (2022) · Journal of Learning Disabilities · doi:10.1177/00222194221099675 · Cited by 12 · see citing works
Ellis, L. A., Blakely, B. D., Hazell, P., Woolfenden, S. R., Hiscock, H., Sarkozy, V., Gould, B. M., Hibbert, P. D., Arnolda, G., Ting, H. P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245916 · Cited by 12 · see citing works
Stigma Related to Observable Symptoms, But Not Stimulant Medication Use, in Young Women With ADHD
Canu, W. H., Cave, M. J., & Nelson, J. M. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231211358 · Cited by 7 · see citing works
Nie, K., Liu, L., Peng, L., Zhang, M., Zhang, C., Xiao, B., Xia, Z., & Huang, W. J. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01971-6 · Cited by 7 · see citing works
Buadze, A., Friedl, N., Schleifer, R., Young, S., Schneeberger, A. R., & Liebrenz, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.600005 · Cited by 9 · see citing works
Jennings, C. A., Singh, B., Oni, H., Mazzacano, A., & Maher, C. A. (2023) · BMC Public Health · doi:10.1186/s12889-023-15382-8 · Cited by 6 · see citing works
Integrating care for neurodevelopmental disorders by unpacking control: A grounded theory study
Waxegård, G., & Thulesius, H. (2016) · International Journal of Qualitative Studies on Health & Well-Being · doi:10.3402/qhw.v11.31987 · Cited by 2 · see citing works
Easy Focus: A Hybrid Solution Designed for Adult ADHD Community
Lin, Q. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-93061-4_20 · Cited by 1 · see citing works
Qiu, S., Luo, X., Luo, Y., Wei, D., & Mei, G. (2022) · Research Square · doi:10.21203/rs.3.rs-1984371/v1
Ching, B. H., Li, Y. H., & Li, X. (2023) · Social Psychology of Education · doi:10.1007/s11218-023-09823-w
Jennings, C. A., Singh, B., Oni, H., Mazzacano, A., & Maher, C. (2024) · Figshare · doi:10.6084/m9.figshare.26578004
Morgan, A. J., Ross, A., McNaught, G., Green, R., & Reavley, N. J. (2026) · The Medical Journal of Australia · doi:10.5694/mja2.70230
(2015) · PubMed Central · Cited by 40 · see citing works
- Authors
- Partridge, B., Lucke, J., & Hall, W.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Partridge, Brad
- Venue
- BMC Psychiatry
- Published
- 2014-03-13
- Volume
- 14
- Issue
- 1
- Pages
- 74-74
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC3975148
- OpenAlex
- W1988618027
- Cited by
- 33
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 1
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Central Queensland University
- Topics
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- public attitudes, psychotropic drugs, depression, attention deficit hyperactivity disorder, overdiagnosis, overtreatment, prescription drug use, mental health stigma, child mental health
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Attitude to Health, Child, Depression, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Practice Patterns, Physicians', Population Surveillance, Public Opinion, Queensland
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review